Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Whitmore

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Developmental Cognitive Neuroscience|June 13, 2024
NowIKnowMyABCD: A global resource hub for researchers using data from the ABCD StudySana A Ali, Clare F McCann, Monica K Thieu, et al.
Urology|April 16, 2013
Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trialPaul F Schellhammer, Gerald Chodak, James B Whitmore, et al.
The Journal of Urology|March 1, 1989
Morbidity and mortality of local failure after definitive therapy for prostate cancerP F Schellhammer, R B Whitmore, D A Kuban, et al.
African Journal of Primary Health Care & Family Medicine|October 12, 2021
A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravirJunaid Omar, Izak Loftus, Nabeelah Vallie, et al.
The Journal of Rheumatology|August 4, 2004
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disabilityScott W Baumgartner, Roy M Fleischmann, Larry W Moreland, et al.
Nursing for Women'S Health|December 6, 2025
Facilitating Culturally Safe Conversations Around Substance Use Disorder and Contraception to Provide Inclusive Care for Neurodiverse and Neurotypical PopulationsLily R Kelyn Bastian, Faith A Ozer Green, Corrie B Whitmore, et al.
Journal of the National Cancer Institute|July 25, 2012
Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancerPhilip W Kantoff, Celestia S Higano, Eric J Small, et al.
Prostate Cancer and Prostatic Diseases|June 25, 2014
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-TE J Small, C S Higano, P W Kantoff, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 1999
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trialL C Borish, H S Nelson, M J Lanz, et al.
Nursing for Women'S Health|February 13, 2025
Did Universal Alcohol Screening and Brief Interventions Delivered in the Context of Reproductive Health Care Universally Reach Demographically Diverse Patients?Megan Waddell, Janice Vendetti, Corrie B Whitmore, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Developmental Cognitive Neuroscience|June 13, 2024
NowIKnowMyABCD: A global resource hub for researchers using data from the ABCD StudySana A Ali, Clare F McCann, Monica K Thieu, et al.
Urology|April 16, 2013
Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trialPaul F Schellhammer, Gerald Chodak, James B Whitmore, et al.
The Journal of Urology|March 1, 1989
Morbidity and mortality of local failure after definitive therapy for prostate cancerP F Schellhammer, R B Whitmore, D A Kuban, et al.
African Journal of Primary Health Care & Family Medicine|October 12, 2021
A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravirJunaid Omar, Izak Loftus, Nabeelah Vallie, et al.
The Journal of Rheumatology|August 4, 2004
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disabilityScott W Baumgartner, Roy M Fleischmann, Larry W Moreland, et al.
Nursing for Women'S Health|December 6, 2025
Facilitating Culturally Safe Conversations Around Substance Use Disorder and Contraception to Provide Inclusive Care for Neurodiverse and Neurotypical PopulationsLily R Kelyn Bastian, Faith A Ozer Green, Corrie B Whitmore, et al.
Journal of the National Cancer Institute|July 25, 2012
Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancerPhilip W Kantoff, Celestia S Higano, Eric J Small, et al.
Prostate Cancer and Prostatic Diseases|June 25, 2014
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-TE J Small, C S Higano, P W Kantoff, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 1999
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trialL C Borish, H S Nelson, M J Lanz, et al.
Nursing for Women'S Health|February 13, 2025
Did Universal Alcohol Screening and Brief Interventions Delivered in the Context of Reproductive Health Care Universally Reach Demographically Diverse Patients?Megan Waddell, Janice Vendetti, Corrie B Whitmore, et al.
Pageof 6